NDC 67877-607 – Buprenorphine And Naloxone

Buprenorphine Hydrochloride 2 mg/1; Naloxone Hydrochloride .5 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC67877-607

Product details

Brand name
Buprenorphine And Naloxone
Generic name
Buprenorphine And Naloxone
Labeler
Ascend Laboratories, LLC
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA214930
Marketed since
July 3, 2026
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (3)

Package NDCDescriptionSince
67877-607-3030 TABLET in 1 BOTTLE (67877-607-30)Jul 3, 2026
67877-607-843 BLISTER PACK in 1 CARTON (67877-607-84) / 10 TABLET in 1 BLISTER PACKJul 3, 2026
67877-607-9090 TABLET in 1 BOTTLE (67877-607-90)Jul 3, 2026

Other Buprenorphine and Naloxone products